Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,713 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200.
Para MF, Schouten J, Rosenkranz SL, Yu S, Weiner D, Tebas P, White CJ, Reeds D, Lertora J, Patterson KB, Daar ES, Cavert W, Brizz B; ACTG A5200 Team of the ACTG. Para MF, et al. Among authors: weiner d. J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):491-5. doi: 10.1097/QAI.0b013e3181d142cb. J Acquir Immune Defic Syndr. 2010. PMID: 20130470 Free PMC article. Clinical Trial.
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial.
Simuni T, Fiske B, Merchant K, Coffey CS, Klingner E, Caspell-Garcia C, Lafontant DE, Matthews H, Wyse RK, Brundin P, Simon DK, Schwarzschild M, Weiner D, Adams J, Venuto C, Dawson TM, Baker L, Kostrzebski M, Ward T, Rafaloff G; Parkinson Study Group NILO-PD Investigators and Collaborators. Simuni T, et al. Among authors: weiner d. JAMA Neurol. 2021 Mar 1;78(3):312-320. doi: 10.1001/jamaneurol.2020.4725. JAMA Neurol. 2021. PMID: 33315105 Free PMC article. Clinical Trial.
Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers.
Maine CJ, Miyake-Stoner SJ, Spasova DS, Picarda G, Chou AC, Brand ED, Olesiuk MD, Domingo CC, Little HJ, Goodman TT, Posy JL, Gonzalez J, Bayone TL, Sparks J, Gary EN, Xiang Z, Tursi NJ, Hojecki CE, Ertl HCJ, Weiner DB, Casmil IC, Blakney AK, Essink B, Somodevilla G, Wang NS, Geall AJ, Goldberg Z, Aliahmad P. Maine CJ, et al. Among authors: weiner db. Nat Commun. 2025 Jan 7;16(1):456. doi: 10.1038/s41467-025-55843-9. Nat Commun. 2025. PMID: 39774967 Free PMC article. Clinical Trial.
Distinguishing Among Causes of Death for Patients with Kidney Failure on Hemodialysis.
Tran M, Xu CA, Wilson J, Ephraim PL, Shafi T, Weiner DE, Goldstein BA, Scialla JJ; Comparative Effectiveness Studies in Dialysis Patients Group; Comparative Effectiveness Studies in Dialysis Patients Group. Tran M, et al. Among authors: weiner de. Kidney360. 2024 Dec 16. doi: 10.34067/KID.0000000681. Online ahead of print. Kidney360. 2024. PMID: 39680439 Free article.
Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune cells.
Park DH, Bhojnagarwala PS, Liaw K, Bordoloi D, Tursi NJ, Zhao S, Binder ZA, O'Rourke D, Weiner DB. Park DH, et al. Among authors: weiner db. J Immunother Cancer. 2024 Dec 2;12(12):e009604. doi: 10.1136/jitc-2024-009604. J Immunother Cancer. 2024. PMID: 39622583 Free PMC article.
1,713 results